Evaluation of the selenotranscriptome expression in two hepatocellular carcinoma cell lines

Analytical Cellular Pathology

Volumn 2015, Issue , 2015, Pages

  Guariniello, Stefano ^a   Di Bernardo, Giovanni ^a   Colonna, Giovanni ^a   Cammarota, Marcella ^a   Castello, Giuseppe ^b   Costantini, Susan ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE PEROXIDASE 3; GLUTATHIONE PEROXIDASE 5; GLUTATHIONE PEROXIDASE 6; GLUTATHIONE PEROXIDASE 7; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PROTEIN DIO1; PROTEIN DIO2; PROTEIN DIO3; PROTEIN SELK; PROTEIN SEP15; PROTEIN SEPHS2; PROTEIN SEPP1; PROTEIN SEPW1; PROTEIN SEPX1; SELENOPROTEIN; SELENOPROTEIN I; SELENOPROTEIN K; SELENOPROTEIN M; SELENOPROTEIN N; SELENOPROTEIN O; SELENOPROTEIN S; SELENOPROTEIN T; SELENOPROTEIN V; SELENOTRANSCRIPTOME; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CANCER PROGNOSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; EVALUATION STUDY; EXERCISE; GENE CONTROL; GENE EXPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HEPG2 CELL LINE; HOUSEKEEPING GENE; HUH7 CELL LINE; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; LIVER TUMOR; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; SELENOPROTEINS; TRANSCRIPTOME; UP-REGULATION;

EID: 84936805369     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.1155/2015/419561     Document Type: Article

References (32)

1. H. B. El-Serag and K. L. Rudolph, "Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, " Gastroenterology, vol. 132, no. 7, pp. 2557-2576, 2007.
2. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, andM. J. Thun, "Cancer statistics, 2007, " CA: A Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43-66, 2007.
3. G. Castello, S. Scala, G. Palmieri, S. A. Curley, and F. Izzo, "HCV-related hepatocellular carcinoma: from chronic inflammation to cancer, " Clinical Immunology, vol. 134, no. 3, pp. 237-250, 2010.
4. S. Costantini, F. Capone, E. Guerriero et al. , "Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection, " PLoS ONE, vol. 7, no. 6, Article ID e39486, 2012.
5. J. Bruix and J. M. Llovet, "Prognostic prediction and treatment strategy in hepatocellular carcinoma, " Hepatology, vol. 35, no. 3, pp. 519-524, 2002.
6. J. Bruix and M. Sherman, "Management of hepatocellular carcinoma, " Hepatology, vol. 42, no. 5, pp. 1208-1236, 2005.
7. S. Costantini, G. Di Bernardo, M. Cammarota, G. Castello, and G. Colonna, "Gene expression signature of human HepG2 cell line, " Gene, vol. 518, no. 2, pp. 335-345, 2013.
8. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, "Free radicals, metals and antioxidants in oxidative stressinduced cancer, " Chemico-Biological Interactions, vol. 160, no. 1, pp. 1-40, 2006.
9. G. V. Kryukov, S. Castellano, S. V. Novoselov et al. , "Characterization of mammalian selenoproteomes, " Science, vol. 300, no. 5624, pp. 1439-1443, 2003.
10. F. P. Bellinger, A. V. Raman, M. A. Reeves, and M. J. Berry, "Regulation and function of selenoproteins in human disease, " Biochemical Journal, vol. 422, no. 1, pp. 11-22, 2009.
11. R. Raucci, G. Colonna, E. Guerriero et al. , "Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma, " Biochimica et Biophysica Acta, vol. 1814, no. 4, pp. 513-522, 2011.
12. M. Di Stasio, M. G. Volpe, G. Colonna et al. , "A possible predictivemarker of progression for hepatocellular carcinoma, " Oncology Letters, vol. 2, no. 6, pp. 1247-1251, 2011.
13. E. Guerriero, M. Accardo, F. Capone, G. Colonna, G. Castello, and S. Costantini, "Assessment of the Selenoprotein M (SELM) over-expression on human hepatocellular carcinoma tissues by immunohistochemistry, " European Journal of Histochemistry, vol. 58, no. 4, 2014.
14. G. di Bernardo, N. Alessio, C. Dell'Aversana et al. , "Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells, " Journal of Cellular Physiology, vol. 225, no. 2, pp. 537-544, 2010.
15. J.-L. Hsieh, C.-L. Wu, C.-H. Lee, and A.-L. Shiau, "Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function, " Clinical Cancer Research, vol. 9, no. 1, pp. 338-345, 2003.
16. S. P. Hussain, J. Schwank, F. Staib, X. W. Wang, and C. C. Harris, "TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer, " Oncogene, vol. 26, no. 15, pp. 2166-2176, 2007.
17. A. F. Brito, A. M. Abrantes, C. Pinto-Costa et al. , "Hepatocellular carcinoma and chemotherapy: the role of p53, " Chemotherapy, vol. 58, no. 5, pp. 381-386, 2013.
18. W. C. Hawkes and Z. Alkan, "Regulation of redox signaling by selenoproteins, " Biological Trace Element Research, vol. 134, no. 3, pp. 235-251, 2010.
19. P. R. Copeland, J. E. Fletcher, B. A. Carlson, D. L. Hatfield, and D. M. Driscoll, "A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs, " The EMBO Journal, vol. 19, no. 2, pp. 306-314, 2000.
20. W. Du, R. Rani, J. Sipple et al. , "The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters, " Blood, vol. 119, no. 18, pp. 4142-4151, 2012.
21. K. L. Bloomfield, S. A. Osborne, D. D. Kennedy, F. M. Clarke, and K. F. Tonissen, "Thioredoxin-mediated redox control of the transcription factor Sp1 and regulation of the thioredoxin gene promoter, " Gene, vol. 319, no. 1-2, pp. 107-116, 2003.
22. C. Guichard, G. Amaddeo, S. Imbeaud et al. , "Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, " Nature Genetics, vol. 44, no. 6, pp. 694-698, 2012.
23. Y. Tomimaru, H. Eguchi, H. Wada et al. , "Insulin-like growth factor-binding protein 7 alters the sensitivity to interferonbased anticancer therapy in hepatocellular carcinoma cells, " British Journal of Cancer, vol. 102, no. 10, pp. 1483-1490, 2010.
24. P. P. Medina, O. A. Romero, T. Kohno et al. , "Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines, " Human Mutation, vol. 29, no. 5, pp. 617-622, 2008.
25. F. Hirano, H. Tanaka, Y. Hirano et al. , "Functional interference of SP1 and NF-B through the same DNA binding site, " Molecular and Cellular Biology, vol. 18, no. 3, pp. 1266-1274, 1998.
26. J.-Y. Chuang, C.-H. Wu, M.-D. Lai, W.-C. Chang, and J.-J. Hung, "Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells, " International Journal of Cancer, vol. 125, no. 9, pp. 2066-2076, 2009.
27. S. Sande and M. L. Privalsky, "Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors, " Molecular Endocrinology, vol. 10, no. 7, pp. 813-825, 1996.
28. H.-K. Choi, K.-C. Choi, H.-B. Kang et al. , "Function ofmultiple lis-homology domain/WD-40 repeat-containing proteins in feed-forward transcriptional repression by silencing mediator for retinoic and thyroid receptor/nuclear receptor corepressor complexes, " Molecular Endocrinology, vol. 22, no. 5, pp. 1093-1104, 2008.
29. C. Curcio-Morelli, A. M. Zavacki, M. Christofollete et al. , "Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation, " The Journal of Clinical Investigation, vol. 112, no. 2, pp. 189-196, 2003.
30. L. A. T. Arnaldi, R. C. Borra, R. M. B. Maciel, and J. M. Cerutti, "Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors, " Thyroid, vol. 15, no. 3, pp. 210-221, 2005.
31. L. Sabatino, G. Iervasi, P. Ferrazzi, D. Francesconi, and I. J. Chopra, "A study of iodothyronine 5-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues, " Life Sciences, vol. 68, no. 2, pp. 191-202, 2000.
32. H. C. Chi, C.-Y. Chen, M.-M. Tsai, C.-Y. Tsai, and K.-H. Lin, "Molecular functions of thyroid hormones and their clinical significance in liver-related diseases, " BioMed Research International, vol. 2013, Article ID 601361, 16 pages, 2013.